Pink Sheet is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Biosimilars: Sandoz Pegfilgrastim Review, Amgen Adalimumab Launch Extended To 2018

Executive Summary

Sandoz needs to do another study to satisfy FDA, while Amgen says it faces a slow pace of patent litigation with AbbVie.

Advertisement

Related Content

Complex Products At US FDA: Adamis' Epi-Pen Alternative OKed; Sandoz Advair ANDA Accepted
Neulasta Biosimilar From Coherus Needs Better Immunogenicity Assay After Stumble At US FDA
Mylan's Next Up For A Shot At Neulasta Biosimilar After Coherus CRL
Can Biosimilar Studies Be Conducted Solely In Healthy Volunteers?
Apotex Moves To Block Coherus' Neulasta Biosimilar; Asks FDA To Require Patient Studies
A Look At Payers' Early Game Plans For Driving Biosimilar Use
How Risky Is Pfizer’s Launch Of Its Remicade Biosimilar?
Coherus, In Ring As A Biosimilar Contender, Hopes To Smack Down Humira
AbbVie v. Amgen Round One: Humira Biosimilar Infringes 10 Patents, Suit Claims
Biosimilars Still Flummoxed By Neulasta: Sponsors Now 0 For 2 At FDA

Topics

Related Companies

Advertisement
UsernamePublicRestriction

Register

PS119422

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel